Pro-Survival Lipid Sphingosine-1-Phosphate Metabolically Programs T Cells to Limit Anti-tumor Activity

Autor: Besim Ogretmen, Shikhar Mehrotra, Rose N. Ngang, Hung Nguyen, Gyda C. Beeson, Paramita Chakraborty, Silvia G. Vaena, Uday K Baliga, Beichu Guo, Meenal Mehrotra, Shahid Husain, Michael J. Zilliox, Krishnamurthy Thyagarajan, Shanmugam Panneer Selvam, In-Hong Kang, Zachariah Hedley, Chrystal M. Paulos, Amir A. Al-Khami, Craig Beeson, Xue-Zhong Yu, Elizabeth G. Hill, Megan W. Wyatt, Shilpak Chatterjee
Jazyk: angličtina
Rok vydání: 2019
Předmět:
0301 basic medicine
Male
Sphingosine-1-phosphate receptor
T cell
Lymphocyte
T-Lymphocytes
Melanoma
Experimental

General Biochemistry
Genetics and Molecular Biology

Article
Oxidative Phosphorylation
03 medical and health sciences
chemistry.chemical_compound
Mice
0302 clinical medicine
Sphingosine
medicine
Animals
Sphingosine-1-phosphate
lcsh:QH301-705.5
S1PR1
Mice
Knockout

biology
Lipid signaling
Cellular Reprogramming
3. Good health
Cell biology
Gene Expression Regulation
Neoplastic

Mice
Inbred C57BL

PPAR gamma
Phosphotransferases (Alcohol Group Acceptor)
Receptors
Lysosphingolipid

030104 developmental biology
medicine.anatomical_structure
lcsh:Biology (General)
chemistry
Sphingosine kinase 1
biology.protein
lipids (amino acids
peptides
and proteins)

Female
Lysophospholipids
030217 neurology & neurosurgery
Signal Transduction
Zdroj: Cell reports
Cell Reports, Vol 28, Iss 7, Pp 1879-1893.e7 (2019)
ISSN: 2211-1247
Popis: SUMMARY Sphingosine 1-phosphate (S1P), a bioactive lysophospholipid generated by sphingosine kinase 1 (SphK1), regulates lymphocyte egress into circulation via S1P receptor 1 (S1PR1) signaling, and it controls the differentiation of regulatory T cells (Tregs) and T helper-17 cells. However, the mechanisms by which receptor-independent SphK1-mediated intracellular S1P levels modulate T cell functionality remains unknown. We show here that SphK1-deficient T cells maintain central memory phenotype and exhibit higher mitochondrial respiration and reduced differentiation to Tregs. Mechanistically, we discovered a direct correlation between SphK1-generated S1P and lipid transcription factor PPARγ (peroxisome proliferator-activated receptor gamma) activity, which in turn regulates lipolysis in T cells. Genetic and pharmacologic inhibition of SphK1 improved metabolic fitness and anti-tumor activity of T cells against murine melanoma. Further, inhibition of SphK1 and PD1 together led to improved control of melanoma. Overall, these data highlight the clinical potential of limiting SphK1/S1P signaling for enhancing anti-tumor-adoptive T cell therapy.
Graphical Abstract
In Brief Chakraborty et al. define the role for SphK1/S1P signaling via engaging lipid transcription factor PPARγ to attenuate lipolysis and spare respiratory capacity in T cells. Genetic ablation or pharmacological inhibition of SphK1 expression limits intrinsic S1P levels and improves T cell-mediated anti-tumor immunotherapeutic control.
Databáze: OpenAIRE